Report Detail
Global (United States, European Union and China) Antidiabetic Drug Market Research Report 2019-2025
- RnM3650743 |
- 06 August, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
In 2019, the market size of Antidiabetic Drug is 49600 million US$ and it will reach 96700 million US$ in 2025, growing at a CAGR of 10.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antidiabetic Drug.
This report studies the global market size of Antidiabetic Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antidiabetic Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Market Segment by Product Type
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Market Segment by Application
Type I Diabetes
Type II Diabetes
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antidiabetic Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antidiabetic Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antidiabetic Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antidiabetic Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Alpha-Glucosidase Inhibitors
- 1.3.3 Biguanides, Sulphonylureas
- 1.3.4 Glp-1 Agonist
- 1.3.5 Meglitinides
- 1.3.6 Dpp-4 Inhibitors
- 1.3.7 Sglt–2
- 1.3.8 Thiazolodinediones
- 1.4 Market Segment by Application
- 1.4.1 Global Antidiabetic Drug Market Share by Application (2019-2025)
- 1.4.2 Type I Diabetes
- 1.4.3 Type II Diabetes
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antidiabetic Drug Market Size
- 2.1.1 Global Antidiabetic Drug Revenue 2014-2025
- 2.1.2 Global Antidiabetic Drug Sales 2014-2025
- 2.2 Antidiabetic Drug Growth Rate by Regions
- 2.2.1 Global Antidiabetic Drug Sales by Regions 2014-2019
- 2.2.2 Global Antidiabetic Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antidiabetic Drug Sales by Manufacturers
- 3.1.1 Antidiabetic Drug Sales by Manufacturers 2014-2019
- 3.1.2 Antidiabetic Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antidiabetic Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Antidiabetic Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antidiabetic Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Antidiabetic Drug Price by Manufacturers
- 3.4 Key Manufacturers Antidiabetic Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antidiabetic Drug Market
- 3.6 Key Manufacturers Antidiabetic Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Alpha-Glucosidase Inhibitors Sales and Revenue (2014-2019)
- 4.1.2 Biguanides, Sulphonylureas Sales and Revenue (2014-2019)
- 4.1.3 Glp-1 Agonist Sales and Revenue (2014-2019)
- 4.1.4 Meglitinides Sales and Revenue (2014-2019)
- 4.1.5 Dpp-4 Inhibitors Sales and Revenue (2014-2019)
- 4.1.6 Sglt–2 Sales and Revenue (2014-2019)
- 4.1.7 Thiazolodinediones Sales and Revenue (2014-2019)
- 4.2 Global Antidiabetic Drug Sales Market Share by Type
- 4.3 Global Antidiabetic Drug Revenue Market Share by Type
- 4.4 Antidiabetic Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antidiabetic Drug Sales by Application
6 United States
- 6.1 United States Antidiabetic Drug Breakdown Data by Company
- 6.2 United States Antidiabetic Drug Breakdown Data by Type
- 6.3 United States Antidiabetic Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Antidiabetic Drug Breakdown Data by Company
- 7.2 European Union Antidiabetic Drug Breakdown Data by Type
- 7.3 European Union Antidiabetic Drug Breakdown Data by Application
8 China
- 8.1 China Antidiabetic Drug Breakdown Data by Company
- 8.2 China Antidiabetic Drug Breakdown Data by Type
- 8.3 China Antidiabetic Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antidiabetic Drug Breakdown Data by Company
- 9.2 Rest of World Antidiabetic Drug Breakdown Data by Type
- 9.3 Rest of World Antidiabetic Drug Breakdown Data by Application
- 9.4 Rest of World Antidiabetic Drug Breakdown Data by Countries
- 9.4.1 Rest of World Antidiabetic Drug Sales by Countries
- 9.4.2 Rest of World Antidiabetic Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Sanofi-Aventis
- 10.1.1 Sanofi-Aventis Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.1.4 Antidiabetic Drug Product Introduction
- 10.1.5 Sanofi-Aventis Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.2.4 Antidiabetic Drug Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 Oramed
- 10.3.1 Oramed Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.3.4 Antidiabetic Drug Product Introduction
- 10.3.5 Oramed Recent Development
- 10.4 Takeda
- 10.4.1 Takeda Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.4.4 Antidiabetic Drug Product Introduction
- 10.4.5 Takeda Recent Development
- 10.5 Boehringer Ingelheim
- 10.5.1 Boehringer Ingelheim Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.5.4 Antidiabetic Drug Product Introduction
- 10.5.5 Boehringer Ingelheim Recent Development
- 10.6 Novo Nordisk
- 10.6.1 Novo Nordisk Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.6.4 Antidiabetic Drug Product Introduction
- 10.6.5 Novo Nordisk Recent Development
- 10.7 Halozyme Therapeutics
- 10.7.1 Halozyme Therapeutics Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.7.4 Antidiabetic Drug Product Introduction
- 10.7.5 Halozyme Therapeutics Recent Development
- 10.8 Bristol-Myers Squibb
- 10.8.1 Bristol-Myers Squibb Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.8.4 Antidiabetic Drug Product Introduction
- 10.8.5 Bristol-Myers Squibb Recent Development
- 10.9 Pfizer
- 10.9.1 Pfizer Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.9.4 Antidiabetic Drug Product Introduction
- 10.9.5 Pfizer Recent Development
- 10.10 Tonghua Dongbao
- 10.10.1 Tonghua Dongbao Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Antidiabetic Drug
- 10.10.4 Antidiabetic Drug Product Introduction
- 10.10.5 Tonghua Dongbao Recent Development
- 10.11 Biocon
- 10.12 Wockhardt
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antidiabetic Drug Sales Channels
- 11.2.2 Antidiabetic Drug Distributors
- 11.3 Antidiabetic Drug Customers
12 Market Forecast
- 12.1 Global Antidiabetic Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Antidiabetic Drug Sales Forecast by Type
- 12.3 Global Antidiabetic Drug Sales Forecast by Application
- 12.4 Antidiabetic Drug Forecast by Regions
- 12.4.1 Global Antidiabetic Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antidiabetic Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antidiabetic Drug. Industry analysis & Market Report on Antidiabetic Drug is a syndicated market report, published as Global (United States, European Union and China) Antidiabetic Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antidiabetic Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
